Spatially resolved transcriptomics (SRT) allows for the comprehensive profiling of gene expression while preserving spatial context, advancing the study of tissue architecture. However, existing computational approaches still face key limitations, particularly the insufficient exploitation of histology information and the lack of cross-modal meaningful contrastive strategies for biological analyses. To overcome these challenges, we propose GCAST, a graph contrastive autoencoder framework for spatial transcriptomics that seamlessly integrates multimodal SRT data. GCAST adopts a self-supervised strategy to derive biologically meaningful representations directly from histology images when available. GCAST constructs dual graph views based on data augmentation and introduces a novel contrastive learning designed to leverage histology-weighted and gene-weighted features and improve biological interpretability. In addition, GCAST employs a block-diagonal graph construction to automatically align multiple datasets, achieving batch-effect correction without manual intervention. The framework not only captures spatial gene expression patterns to identify tissue domains but also adapts to datasets with or without histological images and supports the integration of multiple datasets for joint analyses. Overall, GCAST provides a unified and biologically informed framework that has the potential to facilitate deeper analyses of spatial transcriptomics.

Accurately predicting the pathogenicity of missense variants is crucial for improving disease diagnosis and advancing clinical research. However, existing computational methods primarily focus on general pathogenicity predictions, overlooking assessments of disease-specific conditions. In this study, we propose DS-MVP, a method capable of predicting disease-specific pathogenicity of missense variants in human genomes. DS-MVP first leverages a deep learning model pre-trained on a large general pathogenicity dataset to learn rich representation of missense variants. It then fine-tunes these representations with an XGBoost model on smaller datasets for specific diseases. We evaluated the learned representation by testing it on multiple binary pathogenicity datasets and gene-level statistics, demonstrating that DS-MVP outperforms existing state-of-the-art methods, such as MetaRNN and AlphaMissense. Additionally, DS-MVP excels in multi-label and multi-class classification, effectively classifying disease-specific pathogenic missense variants based on disease conditions. It further enhances predictions by fine-tuning the pre-trained model on disease-specific datasets. Finally, we analyzed the contributions of the pre-trained model and various feature types, with gene description corpus features from large language model and genetic feature fusion contributing the most. These results underscore that DS-MVP represents a broader perspective on pathogenicity prediction and holds potential as an effective tool for disease diagnosis.

MOTIVATION: Protein structure can be severely disrupted by frameshift and non-sense mutations at specific positions in the protein sequence. Frameshift and non-sense mutation cases can also be found in healthy individuals. A method to distinguish neutral and potentially disease-associated frameshift and non-sense mutations is of practical and fundamental importance. It would allow researchers to rapidly screen out the potentially pathogenic sites from a large number of mutated genes and then use these sites as drug targets to speed up diagnosis and improve access to treatment. The problem of how to distinguish between neutral and potentially disease-associated frameshift and non-sense mutations remains under-researched. RESULTS: We built a Transformer-based neural network model to predict the pathogenicity of frameshift and non-sense mutations on protein features and named it TransPPMP. The feature matrix of contextual sequences computed by the ESM pre-training model, type of mutation residue and the auxiliary features, including structure and function information, are combined as input features, and the focal loss function is designed to solve the sample imbalance problem during the training. In 10-fold cross-validation and independent blind test set, TransPPMP showed good robust performance and absolute advantages in all evaluation metrics compared with four other advanced methods, namely, ENTPRISE-X, VEST-indel, DDIG-in and CADD. In addition, we demonstrate the usefulness of the multi-head attention mechanism in Transformer to predict the pathogenicity of mutations-not only can multiple self-attention heads learn local and global interactions but also functional sites with a large influence on the mutated residue can be captured by attention focus. These could offer useful clues to study the pathogenicity mechanism of human complex diseases for which traditional machine learning methods fall short. AVAILABILITY AND IMPLEMENTATION: TransPPMP is available at https://github.com/lennylv/TransPPMP. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Deep learning has been successfully applied to surprisingly different domains. Researchers and practitioners are employing trained deep learning models to enrich our knowledge. Transcription factors (TFs)are essential for regulating gene expression in all organisms by binding to specific DNA sequences. Here, we designed a deep learning model named SemanticCS (Semantic ChIP-seq)to predict TF binding specificities. We trained our learning model on an ensemble of ChIP-seq datasets (Multi-TF-cell)to learn useful intermediate features across multiple TFs and cells. To interpret these feature vectors, visualization analysis was used. Our results indicate that these learned representations can be used to train shallow machines for other tasks. Using diverse experimental data and evaluation metrics, we show that SemanticCS outperforms other popular methods. In addition, from experimental data, SemanticCS can help to identify the substitutions that cause regulatory abnormalities and to evaluate the effect of substitutions on the binding affinity for the RXR transcription factor. The online server for SemanticCS is freely available at http://qianglab.scst.suda.edu.cn/semanticCS/.

The control of the coordinated expression of genes is primarily regulated by the interactions between transcription factors (TFs) and their DNA binding sites, which are an integral part of transcriptional regulatory networks. There are many computational tools focused on determining TF binding or unbinding to a DNA sequence. However, other tools focused on further determining the relative preference of such binding are needed. Here, we propose a regression model with deep learning, called SemanticBI, to predict intensities of TF-DNA binding. SemanticBI is a convolutional neural network (CNN)-recurrent neural network (RNN) architecture model that was trained on an ensemble of protein binding microarray data sets that covered multiple TFs. Using this approach, SemanticBI exhibited superior accuracy in predicting binding intensities compared to other popular methods. Moreover, SemanticBI uncovered vectorized sequence-oriented features using its CNN-RNN architecture, which is an abstract representation of the original DNA sequences. Additionally, the use of SemanticBI raises the question of whether motifs are necessary for computational models of TF binding. The online SemanticBI service can be accessed at http://qianglab.scst.suda.edu.cn/semantic/.